Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Search InvestCenter
Recent Quotes
My Watchlist
Indicators
Isis Pharmaceuticals, Inc. (NQ: ISIS)
20.66 USD  +0.50 (+2.48%)
Official Closing Price  /  Updated: 8:10 PM EDT, May 17, 2013  /  Add to My Watchlist      
View: Quote News Research
All news about Isis Pharmaceuticals, Inc.
 
< Previous 1 2 3 4 5 6 7 8 9
...
41 42 Next >
Aegerion’s Pricing Power Sends Shares Flying
May 17, 2013
Shares of Aegerion Pharmaceuticals (NASDAQ: AEGR) rocketed 33% higher in yesterday’s trading after the company reported that they would increase the price of flagship product Juxtapid (lomitapide) from... Read More
category AEGR , Bio/Wire
from Bio-Wire.Com
Bull’s Eye Report:Isis Pharmaceuticals (ISIS)
May 17, 2013
 Read More
category NASDAQ:ISIS , NYSEARCA:XBI
from InvestorPlace - Latest Headlines
StockCall Early Morning Insight into WCRX, DVAX, ISIS, ACT, and AVNR
May 15, 2013
from ACCESSWIRE
Isis Pharmaceuticals to Present at the 2013 UBS Global Healthcare Conference
May 13, 2013
from PR Newswire
Large Cap Movers (ISIS Pharmaceuticals, Cenveo, Activision Blizzard, Heckmann Corporation)
May 10, 2013
Austin, TX -- (SBWIRE) -- 05/10/2013 -- Jackpotpennystocks.com, an investor research portal specializing in several sectors including biotech and healthcare and tech stocks on the U.S. market, issues... Read More
from SBWire - Latest Press Releases
Snag ISIS Even Lower Than Its Secondary?
May 10, 2013
Looking back to 2 days ago, Isis Pharmaceuticals, Inc. (ISIS) priced a 9,000,000 share secondary stock offering at $19.00 per share. Read More
category Stocks
from Market News Video
Six Superstars for Your Biotech Portfolio: John McCamant
May 09, 2013
Six Superstars for Your Biotech Portfolio: John McCamant Source: Tracy Salcedo-Chourr? of The Life Sciences Report (5/9/13) http://www.thelifesciencesreport.com/pub/na/15256 We are in the “golden age,”... Read More
category AZN , JNJ , ALKS , and 8 more.
from Bio-Wire.Com
Isis Pharmaceuticals Earns $3.5M from Biogen Idec
May 09, 2013
Isis Pharmaceuticals (NASDAQ: ISIS ) announced today that is has earned a $3.5 million milestone payment from Biogen Idec associated with the dosing of the first patient in a Phase 2 study of... Read More
category Contracts , Benzinga , News , and 2 more.
from Latest Articles from Benzinga.com
Isis Pharmaceuticals Earns $3.5 Million from Biogen Idec
May 09, 2013
from PR Newswire
Get Analysts' Downgrades List for May, 10th (MBI, DDD, ISIS, AOL)
May 09, 2013
New York, NY -- (SBWIRE) -- 05/09/2013 -- MBIA Inc. (NYSE:MBI) rose 7.57% to $15.48 after ranging between $14.07and $15.75. The company has decided to pay Societe Generale $350 million to settle... Read More
from SBWire - Latest Press Releases
Isis Pharmaceuticals to Present at the Bank of America Merrill Lynch 2013 Health Care Conference
May 09, 2013
from PR Newswire
Healthcare Stock Watch List: Isis Pharmaceuticals, Inc. (NASDAQ:ISIS), Dendreon Corp. (NASDAQ:DNDN), and Pfizer Inc. (NYSE:PFE) Added to Growing Stock Report's Healthcare Stock Watch List.
May 09, 2013
New York, NY -- (SBWIRE) -- 05/09/2013 -- Growing Stock Report expands its Healthcare Stock Weekly Watch List adding Isis Pharmaceuticals, Inc. (NASDAQ:ISIS), Dendreon Corp. (NASDAQ:DNDN), and Pfizer... Read More
from SBWire - Latest Press Releases
Volume in Focus: Synta Pharmaceuticals Corp.(NASDAQ:SNTA), Suntech Power Holdings Co., Ltd. (ADR)(NYSE:STP), ISIS Pharmaceuticals, Inc. (NASDAQ:ISIS), Coronado Biosciences Inc (NASDAQ:CNDO)
May 09, 2013
Austin, TX -- (SBWIRE) -- 05/09/2013 -- Jackpotpennystocks.com, an investor research portal specializing in several sectors including biotech and healthcare and tech stocks on the U.S. market, issues... Read More
from SBWire - Latest Press Releases
POZEN Inc. (NASDAQ:POZN), Isis Pharmaceuticals, Inc. (NASDAQ:ISIS), and Atossa Genetics, Inc. (NASDAQ:ATOS) Added to Growing Stock Report's NASDAQ Decliners Watch List.
May 09, 2013
New York, NY -- (SBWIRE) -- 05/09/2013 -- Growing Stock Report expands its NASDAQ Decliners Weekly Watch List adding POZEN Inc. (NASDAQ:POZN), Isis Pharmaceuticals, Inc. (NASDAQ:ISIS), and Atossa... Read More
from SBWire - Latest Press Releases
Insights on Options Trading Activity for Isis Pharmaceuticals (ISIS)
May 09, 2013
NEW YORK (AVAFIN) -- During the last trading session, a new 90-day call record ... Read More
from AVAFIN
Isis Pharmaceuticals Prices 9M Share Offering at $19/Share
May 08, 2013
Isis Pharmaceuticals (NASDAQ: ISIS ) announced today the pricing of an underwritten public offering of 9,000,000 shares of its common stock, offered at a price to the public of $19.00 per share. The... Read More
category Contracts , Management , Benzinga , and 4 more.
from Latest Articles from Benzinga.com
Isis Pharmaceuticals Prices Public Offering Of Common Stock
May 08, 2013
from PR Newswire
Upbeat Earnings Boost Markets To Another Record
May 08, 2013
Upbeat earnings boosted the markets further into record territory with the Dow gaining 48 points to 15,105. Nasdaq climbed 16 points to 3413. Read More
category Market News
from MarketMinute.com Market Updates
NASDAQ Decliners Watch List: POZEN Inc. (NASDAQ:POZN), Isis Pharmaceuticals, Inc. (NASDAQ:ISIS), and Atossa Genetics, Inc. (NASDAQ:ATOS) Added to Equity Profile Report's NASDAQ Decliners Watch List.
May 08, 2013
Wilmington, DE -- (SBWIRE) -- 05/08/2013 -- Equity Profile Report expands its NASDAQ Decliners Weekly Watch List adding POZEN Inc. (NASDAQ:POZN), Isis Pharmaceuticals, Inc. (NASDAQ:ISIS), and Atossa... Read More
from SBWire - Latest Press Releases
StreetInsider.com Pre-Open Movers 5/8: (ALXA) (LEDR) (WBMD) Higher; (FIO) (OCLR) (VCLK) Lower (more...)
May 08, 2013
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8316611 for the full story. Read More
from StreetInsider.com News Articles
Streetinsider.com After-Hours Movers 05/07: (WBMD) (WFM) (EA) Higher; (OCLR) (SYNC) (VCLK) Lower (more...)
May 07, 2013
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8314843 for the full story. Read More
from StreetInsider.com News Articles
Isis Pharmaceuticals (ISIS) to Offer 9M Shares
May 07, 2013
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8314835 for the full story. Read More
from StreetInsider.com News Articles
Isis Pharmaceuticals Announces Proposed Public 9M Share Offering of Common Stock
May 07, 2013
Isis Pharmaceuticals (NASDAQ: ISIS ) announced today that it intends to offer for sale 9 million shares of its common stock in an underwritten public offering. In connection with this offering, Isis... Read More
category Benzinga , Offerings , News , and 1 more.
from Latest Articles from Benzinga.com
Isis Pharmaceuticals Announces Proposed Public Offering of Common Stock
May 07, 2013
from PR Newswire
Isis Reports Financial Results and Highlights for First Quarter 2013
May 07, 2013
- Conference Call Webcast Tuesday, May 7, 4:30 p.m. ET at www.isispharm.com Read More
from PR Newswire
Isis Pharmaceuticals, Inc. (ISIS) Reports In-Line Q1 Loss of 2c/Share
May 07, 2013
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8313395 for the full story. Read More
from StreetInsider.com News Articles
Isis Pharma (ISIS) Commences ISIS-STAT3Rx Phase 1b/2a in Advanced HCC
May 06, 2013
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8306205 for the full story. Read More
from StreetInsider.com News Articles
Isis Pharmaceuticals Initiates Clinical Study of ISIS-STAT3 Rx in Liver Cancer Patients
May 06, 2013
Isis Pharmaceuticals, Inc. (NASDAQ: ISIS ) announced the initiation of a Phase 1b/2a clinical study of ISIS-STAT3Rx in patients with advanced metastatic hepatocellular carcinoma (HCC). HCC is a tumor... Read More
category Contracts , Management , Benzinga , and 3 more.
from Latest Articles from Benzinga.com
Isis Pharmaceuticals Announces the Initiation of a Clinical Study of ISIS-STAT3 Rx in Patients with Liver Cancer
May 06, 2013
from PR Newswire
Webcast Alert: Isis Pharmaceuticals' First Quarter 2013 Financial Results Conference Call
May 02, 2013
from PR Newswire
< Previous 1 2 3 4 5 6 7 8 9
...
41 42 Next >
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates Bots go here